Search Results - "FRIEDBERG, S"

Extended Pleurectomy-Decortication–Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years by Friedberg, Joseph S., MD, Simone, Charles B., MD, Culligan, Melissa J., RN, MS, Barsky, Andrew R., BS, Doucette, Abigail, MPH, McNulty, Sally, RN, Hahn, Stephen M., MD, Alley, Evan, MD, PhD, Sterman, Daniel H., MD, Glatstein, Eli, MD, Cengel, Keith A., MD, PhD

“…Background The purpose of this study was to assess survival for patients with malignant pleural mesothelioma (MPM), epithelial subtype, utilizing extended…”
Get full text

The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype by Kandasamy, Sivaveera, Adhikary, Gautam, Rorke, Ellen A, Friedberg, Joseph S, Mickle, McKayla B, Alexander, H Richard, Eckert, Richard L

“…Mesothelioma is an aggressive cancer that has a poor prognosis. Tumors develop in the mesothelial lining of the pleural and peritoneal cavities in response to…”
Get full text

National Cancer Database Report on Pneumonectomy Versus Lung-Sparing Surgery for Malignant Pleural Mesothelioma by Verma, Vivek, Ahern, Christopher A, Berlind, Christopher G, Lindsay, William D, Sharma, Sonam, Shabason, Jacob, Culligan, Melissa J, Grover, Surbhi, Friedberg, Joseph S, Simone, 2nd, Charles B

“…Controversy exists regarding the optimal surgical technique for malignant pleural mesothelioma (MPM). We evaluated national practice patterns and outcomes of…”
Get more information

Radical Pleurectomy and Intraoperative Photodynamic Therapy for Malignant Pleural Mesothelioma by Friedberg, Joseph S., MD, Culligan, Melissa J., BSN, Mick, Rosemarie, MS, Stevenson, James, MD, Hahn, Stephen M., MD, Sterman, Daniel, MD, Punekar, Salman, MD, Glatstein, Eli, MD, Cengel, Keith, MD, PhD

“…Background Radical pleurectomy (RP) for mesothelioma is often considered either technically unfeasible or an operation limited to patients who would not…”
Get full text

Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma by KRUG, Lee M, PASS, Harvey I, OBASAJU, Coleman K, VOGELZANG, Nicholas J, RUSCH, Valerie W, KINDLER, Hedy L, SUGARBAKER, David J, ROSENZWEIG, Kenneth E, FLORES, Raja, FRIEDBERG, Joseph S, PISTERS, Katherine, MONBERG, Matthew

“…Neoadjuvant pemetrexed plus cisplatin was administered, followed by extrapleural pneumonectomy (EPP) and hemithoracic radiation (RT), to assess the feasibility…”
Get full text

Cost‐effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer by Shah, Anand, Hahn, Stephen M., Stetson, Robert L., Friedberg, Joseph S., Pechet, Taine T. V., Sher, David J.

“…BACKGROUND The traditional treatment for clearly operable (CO) patients with stage I non–small cell lung cancer (NSCLC) is lobectomy, with wedge resection (WR)…”
Get full text

Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival by Verma, Vivek, Ahern, Christopher A., Berlind, Christopher G., Lindsay, William D., Shabason, Jacob, Sharma, Sonam, Culligan, Melissa J., Grover, Surbhi, Friedberg, Joseph S., Simone, Charles B.

“…This large investigation evaluates surgical practice patterns and survival by histology for malignant pleural mesothelioma. Histology independently affects…”
Get full text

The State of the Art in the Technical Performance of Lung-Sparing Operations for Malignant Pleural Mesothelioma by Friedberg, Joseph S., MD

“…Malignant pleural mesothelioma remains an incurable disease for which the role of surgery remains controversial. Though not yet clearly defined there does…”
Get full text

Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non–small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location by Schonewolf, Caitlin A., Heskel, Marina, Doucette, Abigail, Singhal, Sunil, Frick, Melissa A., Xanthopoulos, Eric P., Corradetti, Michael N., Friedberg, Joseph S., Pechet, Taine T., Christodouleas, John P., Levin, William, Berman, Abigail, Cengel, Keith A., Verma, Vivek, Hahn, Stephen M., Kucharczuk, John C., Rengan, Ramesh, Simone, Charles B.

“…Stereotactic body radiation therapy is standard for inoperable stage I non–small-cell lung cancer and an emerging surgical alternative in operable patients…”
Get full text

Photodynamic Therapy and the Evolution of a Lung-Sparing Surgical Treatment for Mesothelioma by Friedberg, Joseph S., MD, Mick, Rosemarie, MS, Culligan, Melissa, BSN, Stevenson, James, MD, Fernandes, Annemarie, MD, Smith, Deborah, BSN, Glatstein, Eli, MD, Hahn, Stephen M., MD, Cengel, Keith, MD

“…Background Photodynamic therapy (PDT) is a light-based cancer treatment that acts to a depth of several millimeters into tissue. This study reviewed the…”
Get full text

ACTL6A suppresses p21Cip1 tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype by Shrestha, Suruchi, Adhikary, Gautam, Naselsky, Warren, Xu, Wen, Friedberg, Joseph S., Eckert, Richard L.

“…Mesothelioma is a poor prognosis cancer of the mesothelial lining that develops in response to exposure to various agents including asbestos. Actin-Like…”
Get full text

Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort [version 3; peer review: 2 approved, 1 approved with reservations] by Amin, Waqas, Linkov, Faina, Landsittel, Douglas P, Silverstein, Jonathan C, Bashara, Wiam, Gaudioso, Carmelo, Feldman, Michael D, Pass, Harvey I, Melamed, Jonathan, Friedberg, Joseph S, Becich, Michael J

“…Background: Malignant mesothelioma (MM) is a rare but deadly malignancy with about 3,000 new cases being diagnosed each year in the US.  Very few studies have…”
Get full text

Commentary: “Can we” versus “should we”: The defining dilemma of mesothelioma surgery by Friedberg, Joseph S.

Get full text

320 Oxygenated Peritoneal Perfluorodecalin Improves Response to Normobaric Hypoxic Exposure in Swine by Leibowitz, Joshua L, Awad, Morcos A., Stachnik, Stephen, Moon, Yejin, Kadkhodaeielyaderani, Behzad, Hahn, Jin-Oh, Fathy, Hosam K., Stewart, Shelby J., Friedberg, Joseph S.

“…OBJECTIVES/GOALS: Patients suffering from respiratory failure have few options to support oxygenation and carbon dioxide removal aside from mechanical…”
Get full text

213 Extrapulmonary Gas Exchange Through Peritoneal Perfluorocarbon Perfusion by Leibowitz, Joshua L., Naselsky, Warren, Doosthosseini, Mahsa, Aroom, Kevin, Shah, Aakash, Bittle, Gregory J., Hahn, Jin-Oh, Fathy, Hosam K., Friedberg, Joseph S.

“…OBJECTIVES/GOALS: For patients suffering from respiratory failure there are limited options to support gas exchange aside from mechanical ventilation. Our goal…”
Get full text

CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma by Berger, I., Simpson, Scott, Friedberg, JS, Culligan, Melissa J., Wileyto, E. Paul, Alley, Evan W., Sterman, D., Patel, Akash M., Khalid, U., Simone, CB, Cengel, Keith A., Katz, Sharyn I., Roshkovan, L.

“…•Posterior intercostal node (PILN) metastasis portends poor outcome in mesothelioma.•The PILN nodal group has recently been incorporated into the TMN staging…”
Get full text

Photodynamic therapy for malignant pleural mesothelioma: the future of treatment? by Friedberg, Joseph S

“…Malignant pleural mesothelioma is a deadly incurable cancer, with a median survival of approximately 9 months. The best available chemotherapy, arguably the…”
Get more information

Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma by Du, Kevin L., Both, Stefan, Friedberg, Josephy S., Rengan, Ramesh, Hahn, Stephen M., Cengel, Keith A.

“…Intensity modulated radiation therapy (IMRT) has recently been proposed for the treatment of malignant pleural mesothelioma (MPM). Here, we describe our…”
Get full text

Phase II Trial of Pleural Photodynamic Therapy and Surgery for Patients With Non–Small-Cell Lung Cancer With Pleural Spread by FRIEDBERG, Joseph S, MICK, Rosemarie, HAHN, Stephen M, STEVENSON, James P, ZHU, Timothy, BUSCH, Theresa M, SHIN, Daniel, SMITH, Debbie, CULLIGAN, Melissa, DIMOFTE, Andreea, GLATSTEIN, Eli

“…Non-small-cell lung cancer (NSCLC) with pleural spread is incurable, with median survival rates ranging from 6 to 9 months. Surgery alone fails to locally…”
Get full text

Trial of a novel synthetic sealant in preventing air leaks after lung resection by Wain, John C, Kaiser, Larry R, Johnstone, David W, Yang, Stephen C, Wright, Cameron D, Friedberg, Joseph S, Feins, Richard H, Heitmiller, Richard F, Mathisen, Douglas J, Selwyn, Murray R

“…Background. Postoperative air leaks are a major cause of morbidity after lung resections. This study was designed to evaluate the efficacy and safety of a new…”
Get full text